Market Overview:
The global thyroid cancer testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of thyroid cancer, technological advancements in diagnostic tests, and rising demand for early diagnosis of thyroid cancer. The global thyroid cancer testing market is segmented by type into imaging tests, blood tests, biopsy tests, and other tests. The imaging test segment is further sub-segmented into ultrasound scans, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, and positron emission tomography (PET) scans. The blood test segment is further sub-segmented into thyroglobulin antibody test (TgAb), thyroxine antibodies test (T4Ab), and others. The biopsy test segment is further sub-segmented into fine needle aspiration cytology (FNAC), core needle biopsy (CNB), and surgical biopsy. On the basis of application, the global thyroid cancer testing market is divided into hospital associated labs, independent diagnostic labs., diagnostic imaging centers,,cancer research institutes,,and others segments . Hospital associated labs accounted for the largest share in 2017 owing to increase in number of hospitals across the globe coupled with rising demand for early diagnosis of diseases.
Product Definition:
Thyroid cancer testing is a way to detect thyroid cancer in its earliest stages. It involves taking a sample of cells from the thyroid gland and examining them under a microscope. Thyroid cancer testing is important because it allows doctors to diagnose the disease early, when treatment is most effective.
Imaging Tests:
Imaging tests are the procedures that help doctors to understand the internal structure of a patient's body in order to treat it. Imaging tests include X-ray, ultrasound, CT scan and MRI. These imaging tests are used for different purposes such as identifying cancerous cells in the thyroid gland or scanning injuries suffered by patients during accidents.
The global thyroid cancer testing market is expected to grow at a lucrative rate owing to factors such as growing prevalence of diseases due to changing lifestyle habits.
Blood Tests:
A blood test is a procedure performed to evaluate an individual’s general health and to detect diseases and disorders. In thyroid cancer testing market, blood tests are used for detecting the level of certain chemicals in the body that are produced by the thyroid gland. These tests play an important role in diagnosing various types of cancers such as differentiated carcinoma, medullary thyroid carcinoma, anaplastic carcinoma & follicular lymphoma among others.
Application Insights:
Based on application, the market is segmented into hospital-based labs, independent diagnostic labs, thyroid cancer testing centers and others. Hospital-based thyroid cancer testing accounted for the largest revenue share in 2017 due to increasing prevalence of diseases such as hypothyroidism and hyperthyroidism. Increasing awareness about these diseases among individuals aged 50 years and above is expected to drive demand over the forecast period.
The independent diagnostic lab segment is projected to witness lucrative growth during the forecast period owing to growing awareness regarding availability of various treatment options for patients diagnosed with thyroid cancer at a domestic level as well as globally.
Regional Analysis:
North America dominated the global thyroid cancer testing market in 2017. This can be attributed to the presence of key players, availability of technologically advanced products and high awareness levels coupled with government initiatives. For instance, as per a recent survey conducted by American Cancer Society, Inc., in U.S., more than 1 million people will be diagnosed with thyroid cancer and it is estimated that about 95% of them will survive if treated at an early stage [2]. Thus, increasing prevalence of this disease is one major factor responsible for its dominance during the forecast period.
Asia Pacific region is expected to witness lucrative growth over the forecast period owing to rising disposable income resulting into increased healthcare expenditure along with growing target population base especially in India & China due to better economic conditions compared to other developing countries such as Bangladesh & Pakistan which are also prone to increase incidence rates due lo Thyroid Cancer (source: WHO).
Growth Factors:
- Increasing incidence of thyroid cancer
- Growing awareness about thyroid cancer and its early detection methods
- Rising demand for better and more accurate diagnostic tests for thyroid cancer
- Technological advancements in thyroid cancer testing procedures
- Growing number of research studies on the diagnosis and treatment of thyroid cancer
Scope Of The Report
Report Attributes
Report Details
Report Title
Thyroid Cancer Testing Market Research Report
By Type
Imaging Tests, Blood Tests, Biopsy Tests, Other
By Application
Hospital Associated Labs, Independent Diagnostic Labs, Diagnostic Imaging Centers, Cancer Research Institutes, Others
By Companies
Abbott Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific, Siemens, Bio Rad Laboratories, GE Healthcare, Illumina, Koninklijke Philips, Canon Medical Systems, Agilent Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
153
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Thyroid Cancer Testing Market Report Segments:
The global Thyroid Cancer Testing market is segmented on the basis of:
Types
Imaging Tests, Blood Tests, Biopsy Tests, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Associated Labs, Independent Diagnostic Labs, Diagnostic Imaging Centers, Cancer Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- F. Hoffmann-La Roche
- Thermo Fisher Scientific
- Siemens
- Bio Rad Laboratories
- GE Healthcare
- Illumina
- Koninklijke Philips
- Canon Medical Systems
- Agilent Technologies
Highlights of The Thyroid Cancer Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Imaging Tests
- Blood Tests
- Biopsy Tests
- Other
- By Application:
- Hospital Associated Labs
- Independent Diagnostic Labs
- Diagnostic Imaging Centers
- Cancer Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thyroid Cancer Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Thyroid cancer testing is a process that allows doctors to determine if a person has thyroid cancer. Thyroid cancer can be difficult to detect, and early detection is key for successful treatment. Thyroid cancer testing can include an ultrasound exam, blood tests, and imaging scans.
Some of the major companies in the thyroid cancer testing market are Abbott Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific, Siemens, Bio Rad Laboratories, GE Healthcare, Illumina, Koninklijke Philips, Canon Medical Systems, Agilent Technologies.
The thyroid cancer testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thyroid Cancer Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thyroid Cancer Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thyroid Cancer Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thyroid Cancer Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thyroid Cancer Testing Market Size & Forecast, 2020-2028
4.5.1 Thyroid Cancer Testing Market Size and Y-o-Y Growth
4.5.2 Thyroid Cancer Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Imaging Tests
5.2.2 Blood Tests
5.2.3 Biopsy Tests
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Associated Labs
6.2.2 Independent Diagnostic Labs
6.2.3 Diagnostic Imaging Centers
6.2.4 Cancer Research Institutes
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thyroid Cancer Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thyroid Cancer Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Imaging Tests
9.6.2 Blood Tests
9.6.3 Biopsy Tests
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Associated Labs
9.10.2 Independent Diagnostic Labs
9.10.3 Diagnostic Imaging Centers
9.10.4 Cancer Research Institutes
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Imaging Tests
10.6.2 Blood Tests
10.6.3 Biopsy Tests
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Associated Labs
10.10.2 Independent Diagnostic Labs
10.10.3 Diagnostic Imaging Centers
10.10.4 Cancer Research Institutes
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Imaging Tests
11.6.2 Blood Tests
11.6.3 Biopsy Tests
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Associated Labs
11.10.2 Independent Diagnostic Labs
11.10.3 Diagnostic Imaging Centers
11.10.4 Cancer Research Institutes
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Imaging Tests
12.6.2 Blood Tests
12.6.3 Biopsy Tests
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Associated Labs
12.10.2 Independent Diagnostic Labs
12.10.3 Diagnostic Imaging Centers
12.10.4 Cancer Research Institutes
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Imaging Tests
13.6.2 Blood Tests
13.6.3 Biopsy Tests
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Associated Labs
13.10.2 Independent Diagnostic Labs
13.10.3 Diagnostic Imaging Centers
13.10.4 Cancer Research Institutes
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thyroid Cancer Testing Market: Competitive Dashboard
14.2 Global Thyroid Cancer Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 F. Hoffmann-La Roche
14.3.3 Thermo Fisher Scientific
14.3.4 Siemens
14.3.5 Bio Rad Laboratories
14.3.6 GE Healthcare
14.3.7 Illumina
14.3.8 Koninklijke Philips
14.3.9 Canon Medical Systems
14.3.10 Agilent Technologies
